CONMED Corp. buy Needham & Company LLC
Start price
24.07.23
/
50%
€109.00
Target price
24.07.24
€125.34
Performance (%)
-38.07%
End price
25.07.24
€67.50
Summary
This prediction ended on 25.07.24 with a price of €67.50. Massive losses of -38.07% were the result for the BUY prediction by Needham___Company_LL. A total of €0.74 was paid as dividends for this prediction. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CONMED Corp. | 3.825% | 3.825% | -13.636% | -64.486% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by Needham___Company_LL for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $139.00 price target on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten